Drug profile · INN
trifluridine and tipiracil hydrochloride
LONSURF INITIAL APPROVAL
trifluridine and tipiracil hydrochloride (LONSURF INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — trifluridine and tipiracil hydrochloride
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
trifluridine and tipiracil hydrochloride (LONSURF INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN trifluridine and tipiracil hydrochloride
Brand LONSURF INITIAL APPROVAL
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Frequently asked questions
What is trifluridine and tipiracil hydrochloride?
trifluridine and tipiracil hydrochloride (LONSURF INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for trifluridine and tipiracil hydrochloride?
LONSURF INITIAL APPROVAL is a marketed brand name for trifluridine and tipiracil hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.